Participants sought for occult blood test study at IU School of Medicine
January 14, 2013
INDIANAPOLIS --
The Department of Gastroenterology at the Indiana University School of Medicine is seeking participants for a study comparing stool tests used to detect blood in the colon.
To qualify, participants must already be scheduled for a colonoscopy at the time they enroll in the study.
The fecal occult blood test study is a comparison of stool tests already on the market. Participation can be completed at home, and participants can have the colonoscopy at any location in Indiana. Participants are compensated for their time and the trouble of mailing samples to the laboratory.
For additional information or to enroll, contact Douglas K. Rex, M.D., by phone at 317-948-8393 or by mail at 550 N. University Blvd., Indianapolis, IN 46202.
Related Articles
August 1, 2012 -- The Indiana University School of Medicine is seeking volunteers for an imaging study that may shed light on why some children are more prone to develop substance abuse problems later in life.
July 20, 2012 -- A two-year study of a popular yet controversial weight-loss diet showed no harmful effects on kidney function, according to a study selected as the editor’s choice of the Clinical Journal of the American Society of Nephrology for July 2012.
July 12, 2012 -- Data that has been used for many years to set adolescent calcium intake recommendations in the U.S. and abroad are publicly open to research scientists across the globe for the first time thanks to a collaborative project between Indiana University and Purdue University supported by the Indiana Clinical and Translational Sciences Institute.
July 12, 2012 -- Oral anti-retroviral drugs, taken before exposure to HIV, provided a high level of protection against the virus in heterosexual men and women, according to a study funded by the Bill and Melinda Gates Foundation and published July 12 in the New England Journal of Medicine.
November 1, 2012 -- Physician-researchers at Indiana University School of Medicine have reported the first effective therapy for a class of previously untreatable and potentially life-threatening tumors often found in children.
